Integer Holdings Corporation is a medical device outsource manufacturer serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and power solutions markets.
ITGR Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for ITGR, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Integer Holdings Corp ranked in the 38th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Integer Holdings Corp, consider:
The business' balance sheet suggests that 25% of the company's capital is sourced from debt; this is greater than 54.14% of the free cash flow producing stocks we're observing.
Integer Holdings Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 2.87. This coverage rate is greater than that of 51.63% of stocks we're observing for the purpose of forecasting via discounted cash flows.
The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than 58.62% of stocks in its sector (Healthcare).
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ITGR, try MMSI, CRL, MGLN, PKI, and IART.
PLANO, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full-year 2020, at 8 a.m. Eastern Time (ET) on Thursday, February 18, 2021. Following the release, Integer management will host a webcast at 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, February 18, 2021Time: 9 a.m. ET / 8 a.m. CTDomestic dial-in number: 1-833-714-0898International dial-in number: +1 778-560-2691Conference ID: 1898248Webcast Registration: ITGR Q4 2020 Earnings Call An audio replay will be available for 7 days and can be accessed by dialing 800-585-8367 or 416-621-4642 a...
~ Expansion to Significantly Increase Plant’s Production Capacity of Xcellion® Lithium Ion Rechargeable Batteries ~PLANO, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, today announced that its Alden, N.Y., facility recently broke ground on an expansion to accommodate new equipment that will substantially increase the plant’s production capacity of rechargeable Xcellion® Lithium Ion batteries. With more than 50 years experience, Integer is a worldwide leader in the design, development and manufacture of custom implantable batteries.“Integer continues to make strategic investments to advance our state-of-the-art battery technology and increase capacity to support our customers’ needs,” said Joel B...
"The Medical Device Outsourcing market is growing at a high CAGR during the 2020-2026 forecast period. The growing interest of people in this industry is the main reason for the expansion of this market. While outsourcing isn’t a new phenomenon, its
The scope of the Neurovascular Devices market includes product, application, end user, and region. The market for Neurovascular Devices is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America.